Coronavirus in HIP Fractures CHIP 2: Is Vitamin D Deficiency Associated with Increased Mortality from COVID-19 Infections in A Hip Fracture Population?

##plugins.themes.bootstrap3.article.main##

  •   A. Mahmood

  •   F. Rashid

  •   D. Hawkes

  •   W. J. Harrison

  •   CHIP Collaborative Group

Abstract

Purpose: There is controversy as to whether vitamin D deficiency is associated with increased mortality from coronavirus infection. The aim of the study was to assess the relationship between vitamin D levels and 30-day mortality in hip fracture patients co-infected with COVID-19.


Methods: This was a national observational audit conducted between 23 March 2020 (start of UK lockdown) and 31st December 2020. The cohort consisted of patients aged >60 years presenting with a hip fracture. Patients were included if they had a vitamin D level done during the admission episode, diagnosis of COVID-19 infection via a viral reverse transcriptase PCR swab, and a hip fracture. There were 517 patients included in the study from 43 different hospital trusts. The primary outcome measure was 30-day mortality. Secondary outcomes were the percentage of patients who had vitamin D deficiency, the percentage of patients who were prescribed Vitamin D, and the impact of vitamin D prescribing on mortality


Results: Vitamin D deficiency was not associated with a higher 30-day mortality. Low serum vitamin D was observed in 56% of the patients on admission. Vitamin D was prescribed prior to admission in 28% and during admission in a further 49%. Pre-hospital vitamin D therapy reduced the chance of vitamin D deficiency. Starting vitamin D before or on admission did not affect the mortality rates.


Conclusion: Vitamin D deficiency was common, but not associated with a higher 30-day mortality in the hip fracture population co-infected with COVID-19.


Keywords: COVID-19, hip fracture, SARS-COV-2, vitamin D

References

WHO Coronavirus (COVID-19) Dashboard. [Internet] 2020. [Accessed on March 27, 2021]. Available from: http://covid19.who.int

Boban M. Novel coronavirus disease (COVID-19) update on epidemiology, pathogenicity, clinical course and treatments. Int J Clin Pract. 2021; 75(4): e13868. DOI: https://doi.org/10.1111/ijcp.13868

Mitchell F. Vitamin-D and COVID-19: do deficient risk a poorer outcome? Lancet Diabetes Endocrinol. 2020; 8(7): 570. DOI: https://doi.org/10.1016/S2213-8587(20)30183-2

Ilie PC, Stefanescu S, Smith L. The role of vitamin D in the prevention of coronavirus disease 2019 infection and mortality. Aging Clin Exp Res. 2020; 32(7): 1195-1198. DOI: https://doi.org/10.1007/s40520-020-01570-8

Meltzer DO, Best TJ, Zhang H, Vokes T, Arora V, Solway J. Association of Vitamin D Status and Other Clinical Characteristics With COVID-19 Test Results. JAMA Netw Open. 2020; 3(9): e2019722. DOI: https://doi.org/10.1001/jamanetworkopen.2020.19722

Craveiro V, Cabral M, Araújo J, Falcão H, Guimarães JT, Ramos E. Association of Serum 25-Hydroxyvitamin D Concentration with Pulmonary Function in Young Adults. Nutrients. 2018; 10(11): 1728. DOI: https://doi.org/10.3390/nu10111728

Ginde AA, Mansbach JM, Camargo CA Jr. Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey. Arch Intern Med. 2009; 169(4): 384-90. DOI: https://doi.org/10.1001/archinternmed.2008.560

Martineau AR, Jolliffe DA, Hooper RL, Greenberg L, Aloia JF, Bergman P, et al. Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data. BMJ. 2017; 356: i6583. DOI: https://doi.org/10.1136/bmj.i6583

Laird E, Rhodes J, Kenny RA. Vitamin D and Inflammation: Potential Implications for Severity of Covid-19. Ir Med J. 2020; 113(5): 81.

Panagiotou G, Tee SA, Ihsan Y, Athar W, Marchitelli G, Kelly D, et al. Low serum 25-hydroxyvitamin D (25[OH]D) levels in patients hospitalized with COVID-19 are associated with greater disease severity. Clin Endocrinol (Oxf). 2020; 93(4): 508-511. DOI: https://doi.org/10.1111/cen.14276

Mahmood A, Rashid F, Limb R, Cash T, Nagy MT, Zreik N, et al. Coronavirus infection in hip fractures (CHIP) study. Bone Joint J. 2021; 103-B(4): 782-787. DOI: https://doi.org/10.1302/0301-620X.103B.BJJ-2020-1862.R1

The Caldicott Report. IHRIM. 1999 Jun; 40(2): 17-9 DOI: https://doi.org/10.1111/an.1999.40.6.17.2

Marufu TC, White SM, Griffiths R, Moonesinghe SR, Moppett IK. Prediction of 30-day mortality after hip fracture surgery by the Nottingham Hip Fracture Score and the Surgical Outcome Risk Tool. Anaesthesia. 2016; 71(5): 515-21. DOI: https://doi.org/10.1111/anae.13418

Entrenas Castillo M, Entrenas Costa LM, Vaquero Barrios JM, Alcalá Díaz JF, López Miranda J, Bouillon R, et al. Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study. J Steroid Biochem Mol Biol. 2020; 203: 10575 DOI: https://doi.org/10.1016/j.jsbmb.2020.105751

Murai IH, Fernandes AL, Sales LP, Pinto AJ, Goessler KF, Duran CSC, et al. Effect of a Single High Dose of Vitamin D3 on Hospital Length of Stay in Patients with Moderate to Severe COVID-19: A Randomized Clinical Trial. JAMA. 2021; 325(11): 1053-1060. DOI: https://doi.org/10.1001/jama.2020.26848

Kaufman HW, Niles JK, Kroll MH, Bi C, Holick MF. SARS-CoV-2 positivity rates associated with circulating 25-hydroxyvitamin D levels. PLoS One. 2020; 15(9): e0239252. DOI: https://doi.org/10.1371/journal.pone.0239252

Baktash V, Hosack T, Patel N, Shah S, Kandiah P, Van den Abbeele K et al. Vitamin D status and outcomes for hospitalised older patients with COVID-19. Postgrad Med J. 2021; 97(1149): 442-447. DOI: https://doi.org/10.1136/postgradmedj-2020-138712

Hastie CE, Pell JP, Sattar N. Vitamin D and COVID-19 infection and mortality in UK Biobank. Eur J Nutr. 2021; 60(1): 545-548. DOI: https://doi.org/10.1007/s00394-020-02372-4

Pizzini A, Aichner M, Sahanic S, Böhm A, Egger A, Hoermann G, et al. Impact of Vitamin D Deficiency on COVID-19-A Prospective Analysis from the CovILD Registry. Nutrients. 2020; 12(9): 2775. DOI: https://doi.org/10.3390/nu12092775

Liu N, Sun J, Wang X, Zhang T, Zhao M, Li H. Low vitamin D status is associated with coronavirus disease 2019 outcomes: a systematic review and meta-analysis. Int J Infect Dis. 2021; 104: 58-64. DOI: https://doi.org/10.1016/j.ijid.2020.12.077

Grant WB, Lahore H, McDonnell SL, Baggerly CA, French CB, Aliano JL, et al. Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths. Nutrients. 2020; 12(4): 988. DOI: https://doi.org/10.3390/nu12040988

McCartney DM, Byrne DG. Optimisation of Vitamin D Status for Enhanced Immuno-protection Against Covid-19. Ir Med J. 2020; 113(4): 58.

NICE guideline [NG187] COVID-19 rapid guideline: vitamin D. 2020. [Accessed on March 27, 2021] Available from: https://.nice.org.uk/guidance/NG187

NICE>CKS>Health Topics A to Z >Vitamin D deficiency in adults - treatment and prevention [Accessed 27th March 2021].Available from: http://cks.nice.org.uk/topics/vitamin-d-deficiency-in-adults/management

Downloads

Download data is not yet available.

##plugins.themes.bootstrap3.article.details##

How to Cite
Mahmood, A., Rashid, F., Hawkes, D., Harrison, W. J., & CHIP Collaborative Group. (2021). Coronavirus in HIP Fractures CHIP 2: Is Vitamin D Deficiency Associated with Increased Mortality from COVID-19 Infections in A Hip Fracture Population?. European Journal of Medical and Health Sciences, 3(6), 111–116. https://doi.org/10.24018/ejmed.2021.3.6.1159